Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.